The outcomes of COVID-19 pneumonia in children-clinical, radiographic, and pulmonary function assessment.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
04 2023
Historique:
revised: 15 12 2022
received: 29 06 2022
accepted: 20 12 2022
pubmed: 24 12 2022
medline: 21 3 2023
entrez: 23 12 2022
Statut: ppublish

Résumé

The goal of this study was to assess the pulmonary sequelae of COVID-19 pneumonia in children. Children (0-18 years old) diagnosed with COVID-19 pneumonia hospitalized between March 2020 and March 2021 were included in this observational study. All children underwent follow-up visits 3 months postdischarge, and if any abnormalities were stated, a second visit after the next 3 months was scheduled. Clinical assessment included medical history, physical examination, lung ultrasound (LUS) using a standardized protocol, and pulmonary function tests (PFTs). PFTs results were compared with healthy children. Forty-one patients with COVID-19 pneumonia (severe disease n = 3, mechanical ventilation, n = 0) were included in the study. Persistent symptoms were reported by seven (17.1%) children, the most common was decreased exercise tolerance (57.1%), dyspnea (42.9%), and cough (42.9%). The most prevalent abnormalities in LUS were coalescent B-lines (37%) and small subpleural consolidations (29%). The extent of LUS abnormalities was significantly greater at the first than at the second follow-up visit (p = 0.03). There were no significant differences in PFTs results neither between the study group and healthy children nor between the two follow-up visits in the study group. Our study shows that children might experience long-term sequelae following COVID-19 pneumonia. In the majority of cases, these are mild and resolve over time.

Identifiants

pubmed: 36562653
doi: 10.1002/ppul.26291
pmc: PMC9880754
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1042-1050

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

World Health Organization. Accessed October 31, 2022. https://covid19.who.int/
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.
Cohen JF, Korevaar DA, Matczak S, Chalumeau M, Allali S, Toubiana J. COVID-19-related fatalities and intensive-care-unit admissions by age groups in Europe: a meta-analysis. Front Med. 2020;7:560685.
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-1095.
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242.
Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-151.
Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653-661.
Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663-1665.
Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS, Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Arch Dis Child. 2021;106(5):440-448.
Moreno-Galarraga L, Taveras EM. COVID-19 disease in children: not as mild as we have been led to believe. World J Pediatr. 2020;16(4):426-427.
Castagnoli R, Votto M, Licari A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020;174(9):882-889.
Williams N, Radia T, Harman K, Agrawal P, Cook J, Gupta A. COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities. Eur J Pediatr. 2021;180(3):689-697.
Pokorska-Śpiewak M, Talarek E, Mania A, et al. Clinical and epidemiological characteristics of 1283 pediatric patients with coronavirus disease 2019 during the first and second waves of the pandemic-results of the pediatric part of a Multicenter Polish Register SARSTer. Journal of Clinical Medicine. 2021;10(21):5098.
Mania A, Pokorska-Śpiewak M, Figlerowicz M, et al. Pneumonia, gastrointestinal symptoms, comorbidities, and coinfections as factors related to a lengthier hospital stay in children with COVID-19-analysis of a paediatric part of Polish register SARSTer. Infect Dis. 2022;54(3):196-204.
Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J. 2020;39(6):469-477.
Hizal M, Aykac K, Yayla BCC, et al. Diagnostic value of lung ultrasonography in children with COVID-19. Pediatr Pulmonol. 2021;56(5):1018-1025.
Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for long covid in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J. 2021;59:2101341.
Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S, et al. Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J. 2021;40(12):e509-e511.
Asadi-Pooya AA, Nemati H, Shahisavandi M, et al. Long COVID in children and adolescents. World J Pediatr. 2021;17(5):495-499.
Roge I, Smane L, Kivite-Urtane A, et al. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front Pediatr. 2021;9:752385.
Zimmermann P, Pittet LF, Curtis N. Long covid in children and adolescents. BMJ. 2022;376:o143.
World Health Organization. Clinical Management of COVID-19: Interim Guidance, 2020.
Soldati G, Smargiassi A, Inchingolo R, et al. Proposal for international standardization of the use of lung ultrasound for patients with COVID-19: a simple, quantitative, reproducible method. J Ultrasound Med. 2020;39(7):1413-1419.
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968.
Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016.
Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324-1343.
Dencker M, Malmberg LP, Valind S, et al. Reference values for respiratory system impedance by using impulse oscillometry in children aged 2-11 years. Clin Physiol Funct Imaging. 2006;26(4):247-250.
Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods, reference values. Progr Respir Res. 1987;22:83-112.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.
Denina M, Pruccoli G, Scolfaro C, et al. Sequelae of COVID-19 in hospitalized children: a 4-months follow-up. Pediatr Infect Dis J. 2020;39(12):e458-e459.
Leftin Dobkin SC, Collaco JM, McGrath-Morrow SA. Protracted respiratory findings in children post-SARS-CoV-2 infection. Pediatr Pulmonol. 2021;56(12):3682-3687.
Bottino I, Patria MF, Milani GP, et al. Can asymptomatic or non-severe SARS-CoV-2 infection cause medium-term pulmonary sequelae in children? Front Pediatr. 2021;9:621019.
COVID symptom study. How long does COVID-19 last? Kings College London. 2020. Accessed November 09, 2022. https://covid19.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397(10270):220-232.
National Institute for Health and Care Excellence: clinical guidelines. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE) Copyright © NICE; 2020.
Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Italian J Pediatr. 2021;47(1):177.
Isoldi S, Mallardo S, Marcellino A, et al. The comprehensive clinic, laboratory, and instrumental evaluation of children with COVID-19: a 6-months prospective study. J Med Virol. 2021;93(5):3122-3132.
Maddux AB, Berbert L, Young CC, et al. Health impairments in children and adolescents after hospitalization for acute COVID-19 or MIS-C. Pediatrics. 2022;150(3):e2022057798.
Lopez-Leon S, Wegman-Ostrosky T, Ayuzo del Valle NC, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.
Behnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158-170.
Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110(3):914-921.
Say D, Crawford N, McNab S, Wurzel D, Steer A, Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22-e23.
Buonsenso D, Munblit D, De Rose C, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208-2211.
Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708-718.
Sterky E, Olsson-Åkefeldt S, Hertting O, et al. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021;110(9):2578-2580.
Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326(9):869-871.
Brackel CLH, Lap CR, Buddingh EP, et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr Pulmonol. 2021;56(8):2495-2502.
Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181:3995-4009.
Valenzuela G, Alarcón-Andrade G, Schulze-Schiapacasse C, et al. Short-term complications and post-acute sequelae in hospitalized paediatric patients with COVID-19 and obesity: a multicenter cohort study. Pediatr Obes. 2022;12:e12980.
Kumar J, Meena J, Yadav A, Yadav J. Radiological findings of COVID-19 in children: a systematic review and meta-analysis. J Trop Pediatr. 2020;67(3):fmaa045.
Norbedo S, Blaivas M, Raffaldi I, Caroselli C. Lung ultrasound point-of-view in pediatric and adult COVID-19 infection. J Ultrasound Med. 2021;40(5):899-908.
Kennedy TM, Malia L, Dessie A, et al. Lung point-of-care ultrasound in pediatric COVID-19: a case series. Pediatr Emerg Care. 2020;36(11):544-548.
Caroselli C, Blaivas M, Falzetti S. Diagnostic imaging in newborns, children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): is there a realistic alternative to lung high-resolution computed tomography (HRCT) and chest X-Rays? A systematic review of the literature. Ultrasound Med Biol. 2021;47(11):3034-3040.
Musolino AM, Supino MC, Buonsenso D, et al. Lung ultrasound in children with COVID-19: preliminary findings. Ultrasound Med Biol. 2020;46(8):2094-2098.
Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328-337.

Auteurs

Stanisław Bogusławski (S)

Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.

Agnieszka Strzelak (A)

Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.

Kacper Gajko (K)

Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.

Joanna Peradzyńska (J)

Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.
Department of Epidemiology and Biostatistics, Medical University of Warsaw, Warsaw, Poland.

Jolanta Popielska (J)

Department of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.

Magdalena Marczyńska (M)

Department of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.

Marek Kulus (M)

Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.

Katarzyna Krenke (K)

Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH